Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.

A device developed by the Institute of Bioengineering of Catalonia and the Research Institute of Hospital del Mar allows replicating tumors and their environment to analyze the response to therapies.